Adalimumab vs Tildrakizumab

## Adalimumab vs Tildrakizumab: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Tildrakizumab**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Tildrakizumab — N/A.

## Chemical Properties

**Type**: Adalimumab — Antibody; Tildrakizumab — Antibody.